Since 4E-BP1 is the substrate whereby mTORC1 regulates cell proliferation, the inadequate inhibition of this strong and stable molecule can be considered a plausible explanation of the modest antiproliferative efficacy of rapamycin on tumor cells [371, 372]. The gene discussed is EIF4EBP1; the disease is neoplasm.